According to Nykode Therapeutics's latest financial reports the company has ยฃ0.10 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | ยฃ0.17 B | 0.76% |
2021-12-31 | ยฃ0.16 B | 10.48% |
2020-12-31 | ยฃ0.15 B | 5492.69% |
2019-12-31 | ยฃ2.73 M | 81.88% |
2018-12-31 | ยฃ1.5 M | -33.71% |
2017-12-31 | ยฃ2.26 M |